Drug Approval | August 13, 2025
Indoco Remedies receives final USFDA approval for rivaroxaban tablets
Rivaroxaban is used to treat venous thromboembolism
Rivaroxaban is used to treat venous thromboembolism
The company reported a 28% year-on-year increase in Q2 revenue to Rs. 220.9 crore
cSCC is one of the most common cancers in the U.S. and globally
A global platform advancing pharmaceutical collaboration, innovation, and exports—powering healthcare and connecting markets worldwide
This year, the OCTF focused on preparing a white paper on oral cancer elimination in India and updating its annual consensus guidelines
Both these products will be manufactured at Lupin’s Injectable facility at Nagpur, India
FDA requests Sarepta Therapeutics to suspend distribution of Elevidys and places clinical trials on hold for multiple gene therapy products following 3 deaths
Reblozyl is a standard of care for the first-line treatment of anemia without previous erythropoiesis stimulating agent use
Apotex will also pay US$ 2.5 million upon receipt of final USFDA approval of the ANDA that is the subject of the Collaboration Agreement for Paclitaxel Protein-Bound Particles for Injectable Suspension
It is intended for contrast enhancement in MRI scans
Subscribe To Our Newsletter & Stay Updated
